Elanco Animal Health Incorporated· ELAN

🇺🇸 US · LargeSP400NYSE

Healthcare Drug Manufacturers - Specialty & Generic Website

Price: $22.42
Day: -1.41%
Mkt Cap: $11.20B
52W Range: $18.48 – $27.98
Volume: 7.91M
Beta: 1.68

D25D FrameworkTTM Data

Peer Comparison

Performance vs sector and industry peers across 40 metrics.

Peer Comparison: 2.0 / 5 (Weak) against 87 sector peers in United States · Large Cap · Healthcare
Pillars: strongest Valuation Multiples 4.0, weakest Operational Efficiency 1.0 (9 of 10 ranked)
Ranks: ROIC 26th percentile, operating margin 38th percentile

Blog

stockoscope.com

Elanco Animal Health Incorporated

ELAN|Healthcare|Drug Manufacturers - Specialty & Generic

Comparing against 87 sector peers in United States · Large Cap · Healthcare

Peer Comparison

Dimension 2 of 5

Revenue Growth

66%ile

11.9%

Operating Margin

38%ile

9.2%

ROIC

26%ile

3.9%

FCF Yield

38%ile

3.4%

Growth & Cash Flow Quality

Percentile ranking across profitability growth and cash generation

EBITDA Growth

-49.3%

EBIT Growth

-90.6%

Net Income Growth

-145.8%

OCF Growth

7.9%

FCF Growth

6.8%

Income Quality

-3.98

Returns on Capital (TTM)

ROE(-3.0%)

22%ile

Below Avg

PoorWeakAdequateStrongExceptional

ROCE(4.0%)

25%ile

Below Avg

PoorWeakAdequateStrongExceptional

ROA(-1.5%)

18%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROIC(3.9%)

26%ile

Below Avg

PoorWeakAdequateStrongExceptional

Profit Margins (TTM)

Gross Margin(52.6%)

43%ile

Average

PoorWeakAdequateStrongExceptional

EBITDA Margin(15.4%)

37%ile

Below Avg

PoorWeakAdequateStrongExceptional

Operating Margin(9.2%)

38%ile

Below Avg

PoorWeakAdequateStrongExceptional

Net Margin(-4.0%)

15%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Leverage & Coverage (TTM)

Debt/Equity

58%ile

0.59

Debt/Capital

58%ile

0.37

Net Debt/EBITDA

18%ile

4.38

Interest Coverage

18%ile

1.78x

Liquidity (TTM)

Current Ratio

65%ile

2.05

Quick Ratio

29%ile

1.09

Cash Ratio

34%ile

0.29

WC Turnover

45%ile

2.60

Operational Efficiency (TTM)

Asset Turnover

13%ile

0.37

DSO

17%ile

83.8

Days Inventory

13%ile

271

Cash Conv. Cycle

10%ile

290

TTM: Trailing Twelve Months · EBITDA: Earnings Before Interest, Taxes, Depreciation & Amortization · EBIT: Earnings Before Interest & Taxes · ROA: Return on Assets · ROIC: Return on Invested Capital · ROCE: Return on Capital Employed · ROE: Return on Equity · OCF: Operating Cash Flow · FCF: Free Cash Flow · DSO: Days Sales Outstanding · WC: Working Capital

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore ELAN on stockoscope.com→

Generated September 21, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

87 sector peers (United States · Large Cap · Healthcare)

Relative Quality

ELAN Relative Quality Score

Ranked against 87 sector peers in United States · Large Cap · Healthcare

Relative Quality

2.0/5

Weak

vs 87 sector peers

Peer Rankings (9 of 10 available)

Relative Quality Score of 2.02/5 (Weak) based on percentile rankings against 87 sector peers in United States · Large Cap · Healthcare. Each pillar shows a 1-5 score plus the cohort percentile (e.g. 95p = top 5%); higher percentiles indicate stronger relative performance.Last updated September 20, 2026.

Top-Line and Profit Growth

How does the company's growth rate compare to peers?

Revenue Growth

66th percentile, Strong

Value: 11.95%
Percentile: 66%
Score: 4/5

PoorWeakAdequateStrongExceptional

Analysis

ELAN has a ttm revenue growth of 11.95% and ranks at the 66th percentile vs United States · Healthcare sector peers. Strong financial performance.

Margin Efficiency

Does the company maintain better profit margins than peers?

Gross Margin

43rd percentile, Adequate

Value: 52.59%
Percentile: 43%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

ELAN has a ttm gross margin of 52.59% and ranks at the 43rd percentile vs United States · Healthcare sector peers. Adequate financial performance.

Operational Efficiency

Is the company more operationally efficient than competitors?

Asset Turnover

13th percentile, Poor

Value: 0.37
Percentile: 13%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

ELAN has a ttm asset turnover of 0.37 and ranks at the 13th percentile vs United States · Healthcare sector peers. Poor financial performance.

Returns Overview

Does the company generate better returns on capital than peers?

ROA

18th percentile, Poor

Value: -1.47%
Percentile: 18%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

ELAN has a ttm roa of -1.47% and ranks at the 18th percentile vs United States · Healthcare sector peers. Poor financial performance.

Cash Flow Quality

How does the company's cash generation compare to peers?

Operating Cash Flow Growth

51st percentile, Adequate

Value: 7.87%
Percentile: 51%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

ELAN has a ttm operating cash flow growth of 7.87% and ranks at the 51st percentile vs United States · Healthcare sector peers. Adequate financial performance.

Liquidity and Working Capital

Does the company maintain better liquidity positions than competitors?

Cash Ratio

34th percentile, Weak

Value: 0.29
Percentile: 34%
Score: 2/5

PoorWeakAdequateStrongExceptional

Analysis

ELAN has a ttm cash ratio of 0.29 and ranks at the 34th percentile vs United States · Healthcare sector peers. Below average financial performance.

Leverage and Coverage

Is the company's debt burden more manageable than peers?

Debt to Capital

58th percentile, Adequate

Value: 0.37
Percentile: 58%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

ELAN has a ttm debt-to-capital of 0.37 and ranks at the 58th percentile vs United States · Healthcare sector peers. Adequate financial performance.

Valuation Multiples

Is the company's stock valuation attractive relative to peers?

P / E Ratio

Insufficient peer data

Value: -54.68
Percentile: n/a
Score: n/a

PoorWeakAdequateStrongExceptional

Analysis

Not enough peer data to rank ELAN for ttm p/e ratio in this cohort.

Dividend and Shareholder Yield

Does the company deliver superior income to shareholders compared to peers?

No data for Dividend Yield is available for ELAN, so peer comparison is hidden for this metric. Try another metric.

Peer companies

The 87 companies ELAN is compared against across its sector and industry cohorts.

Peer Comparison

Performance vs sector and industry peers across 40 metrics.

Peer Comparison: 2.0 / 5 (Weak) against 87 sector peers in United States · Large Cap · Healthcare

Pillars: strongest Valuation Multiples 4.0, weakest Operational Efficiency 1.0 (9 of 10 ranked)

Ranks: ROIC 26th percentile, operating margin 38th percentile

Elanco Animal Health Incorporated· ELAN

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies

Search stocks

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies